carbamates has been researched along with Dyslipidemias in 6 studies
Dyslipidemias: Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Healthy volunteer studies have demonstrated a decrease in glucose disposal associated with dosing with specific antiretrovirals." | 6.75 | Effect of boosted fosamprenavir or lopinavir-based combinations on whole-body insulin sensitivity and lipids in treatment-naive HIV-type-1-positive men. ( Back, DJ; Boffito, M; Jackson, AG; Mandalia, S; Moyle, GJ; Randell, PA; Taylor, J; Tjia, JF, 2010) |
| " Healthy volunteer studies have demonstrated a decrease in glucose disposal associated with dosing with specific antiretrovirals." | 2.75 | Effect of boosted fosamprenavir or lopinavir-based combinations on whole-body insulin sensitivity and lipids in treatment-naive HIV-type-1-positive men. ( Back, DJ; Boffito, M; Jackson, AG; Mandalia, S; Moyle, GJ; Randell, PA; Taylor, J; Tjia, JF, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, CF | 1 |
| Dai, CY | 1 |
| Yeh, ML | 1 |
| Huang, CI | 1 |
| Lee, HC | 1 |
| Lai, WT | 1 |
| Liang, PC | 1 |
| Lin, YH | 1 |
| Hsieh, MY | 1 |
| Hou, NJ | 1 |
| Lin, ZY | 1 |
| Chen, SC | 1 |
| Huang, JF | 1 |
| Chuang, WL | 1 |
| Yu, ML | 1 |
| Jain, A | 1 |
| Kalra, BS | 1 |
| Srivastava, S | 1 |
| Chawla, S | 1 |
| Ucciferri, C | 1 |
| Falasca, K | 1 |
| Vignale, F | 1 |
| Di Nicola, M | 1 |
| Pizzigallo, E | 1 |
| Vecchiet, J | 1 |
| Helsley, RN | 1 |
| Sui, Y | 1 |
| Ai, N | 1 |
| Park, SH | 1 |
| Welsh, WJ | 1 |
| Zhou, C | 1 |
| Pombo, M | 1 |
| Olalla, J | 1 |
| Del Arco, A | 1 |
| De La Torre, J | 1 |
| Urdiales, D | 1 |
| Aguilar, A | 1 |
| Prada, JL | 1 |
| García-Alegría, J | 1 |
| Ruiz-Mateas, F | 1 |
| Randell, PA | 1 |
| Jackson, AG | 1 |
| Boffito, M | 1 |
| Back, DJ | 1 |
| Tjia, JF | 1 |
| Taylor, J | 1 |
| Mandalia, S | 1 |
| Moyle, GJ | 1 |
1 trial available for carbamates and Dyslipidemias
| Article | Year |
|---|---|
Effect of boosted fosamprenavir or lopinavir-based combinations on whole-body insulin sensitivity and lipids in treatment-naive HIV-type-1-positive men.
Topics: Adenine; Adipose Tissue; Adult; Anti-HIV Agents; Blood Glucose; Carbamates; Confidence Intervals; Dr | 2010 |
5 other studies available for carbamates and Dyslipidemias
| Article | Year |
|---|---|
Cure or curd: Modification of lipid profiles and cardio-cerebrovascular events after hepatitis C virus eradication.
Topics: Aged; Antiviral Agents; Carbamates; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Dys | 2020 |
Effect of sofosbuvir and daclatasvir on lipid profile, glycemic control and quality of life index in chronic hepatitis C, genotype 3 patients.
Topics: Administration, Oral; Adolescent; Adult; Antiviral Agents; Carbamates; Cholesterol; Dexamethasone; D | 2019 |
Improved metabolic profile after switch to darunavir/ritonavir in HIV positive patients previously on protease inhibitor therapy.
Topics: Adult; Anti-HIV Agents; Blood Chemical Analysis; Carbamates; CD4 Lymphocyte Count; Darunavir; Dyslip | 2013 |
Pregnane X receptor mediates dyslipidemia induced by the HIV protease inhibitor amprenavir in mice.
Topics: Animals; Binding Sites; Carbamates; Cell Line; Dyslipidemias; Furans; Gene Expression; HIV Protease | 2013 |
Left ventricular hypertrophy detected by echocardiography in HIV-infected patients.
Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Carba | 2013 |